| Title |
Standardizing the Benefit-Risk Assessment of New Medicines
|
|---|---|
| Published in |
Pharmaceutical Medicine, August 2012
|
| DOI | 10.1007/bf03256855 |
| Authors |
Lawrence Liberti, James Neil McAuslane, Stuart Walker |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 10% |
| Unknown | 9 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 2 | 20% |
| Student > Ph. D. Student | 1 | 10% |
| Professor > Associate Professor | 1 | 10% |
| Other | 1 | 10% |
| Unknown | 5 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Business, Management and Accounting | 2 | 20% |
| Social Sciences | 2 | 20% |
| Medicine and Dentistry | 1 | 10% |
| Unknown | 5 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2022.
All research outputs
#7,682,308
of 23,376,718 outputs
Outputs from Pharmaceutical Medicine
#55
of 152 outputs
Outputs of similar age
#56,723
of 170,593 outputs
Outputs of similar age from Pharmaceutical Medicine
#4
of 20 outputs
Altmetric has tracked 23,376,718 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 152 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,593 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.